News

Article

Lohxa Recalls Senna Syrup

The company is voluntarily recalling one lot of Senna Syrup 8.8mg/5mL, unit-dose cups because of microbial contamination.

Lohxa LLC announced on Jan. 11, 2022, that it is voluntarily recalling one lot of Senna Syrup 8.8 mg/5mL, unit-dose cups due to microbial contamination. Senna Syrup is a natural vegetable laxative and is packaged in 5-mL unit-dose cups. The affected lot is AM1115S with expiration date of 01/2023 and was distributed to a wholesaler, AvKare. The product may then have been distributed by AvKare to clinics, hospitals, and healthcare providers.

According to the company, use of the contaminated product could be life threatening in patients who are elderly, have weakened immune systems, or who are at risk for heart inflammation. The company has not, as of the date of the press release, received any reports of adverse events related to the recall.

Source: FDA

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More